Armistice Capital, LLC Xeris Biopharma Holdings, Inc. Transaction History

Armistice Capital, LLC

  • $6.02 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$1.37 - $1.93 $4.55 Million - $6.41 Million
-3,319,569 Reduced 57.0%
2,504,431 $3.91 Million
Q2 2022

Aug 15, 2022
SELL
$1.48 - $2.64 $2.43 Million - $4.33 Million
-1,640,993 Reduced 21.98%
5,824,000 $8.97 Million
Q1 2022

May 16, 2022
BUY
$2.0 - $2.87 $14.9 Million - $21.4 Million
7,464,993 New
7,464,993 $19.1 Million

Others Institutions Holding XERS

# of Institutions
143
Shares Held
60M
Call Options Held
148K
Put Options Held
45.7K
View Full List

About Xeris Biopharma Holdings, Inc.

XERS Quotes by TradingView
  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $462M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email